FENC Stock-Based Compensation
Fennec Pharmaceuticals Inc · Stock-Based Compensation
FENC Stock-Based Compensation
Latest reported$1.77Mperiod ending
FENC Quarterly Stock-Based Comp ($0.00 → $1.77M)
Quarterly stock-based compensation
High-resolution chart · PNG
FENC stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 1,774,000 | |
| 0 | |
| 2,522,000 | |
| 2,219,000 | |
| 1,494,000 | |
| 798,000 | |
| 1,124,000 | |
| 1,821,000 | |
| 925,000 | |
| 1,191,000 | |
| 857,000 | |
| 865,000 | |
| 2,543,000 | |
| 1,089,000 | |
| 857,000 | |
| 1,887,000 | |
| 1,008,000 | |
| 399,000 | |
| 910,000 | |
| 917,000 | |
| 1,326,000 | |
| 596,000 | |
| 577,000 | |
| 1,259,000 | |
| 543,000 | |
| 412,000 | |
| 66,000 | |
| 335,000 | |
| 2,000,000 | |
| 264,000 | |
| -21,000 | |
| 268,000 | |
| 1,290,000 | |
| 288,000 | |
| -444,000 | |
| 1,117,000 | |
| 747,000 | |
| 41,000 | |
| 463,000 | |
| 41,000 | |
| 111,000 | |
| 13,000 | |
| 69,000 | |
| 9,000 | |
| 10,000 | |
| 9,000 | |
| 88,000 | |
| 67,000 | |
| 339,000 | |
| 133,000 | |
| -10,000 | |
| 41,000 | |
| 29,000 | |
| 0 | |
| 271,000 | |
| 3,000 | |
| 17,000 | |
| 0 | |
| 44,000 | |
| 157,000 | |
| 49,000 | |
| 0 | |
| -385,000 | |
| 385,000 | |
| 2,054,000 | |
| 0 | |
| -9,000 | |
| 9,000 | |
| 0 | |
| 0 | |
| 0 | |
| 280,000 | |
| 19,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,241,000 | |
| 163,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -271,005 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |